FDA Import Refusal AEK-8689322-6/11/1 — Glasxosmithkline Pharmaceuticals
The FDA refused shipment AEK-8689322-6/11/1 from Glasxosmithkline Pharmaceuticals (India) on Feb 3, 2021. The refused product falls under Drugs and Biologics — THYROXINE I 125 (RADIOACTIVE AGENT). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Feb 3, 2021
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 65NDY76 THYROXINE I 125 (RADIOACTIVE AGENT)
- Charges
- 75